Literature DB >> 20590564

How important are sex differences in cannabinoid action?

Liana Fattore1, Walter Fratta.   

Abstract

In humans as in animals, males and females are dissimilar in their genetic and hormonally driven behaviour; they process information differently, perceive experience and emotions in different ways, display diverse attitudes, language and social skills, and show sex-related differences in the brain anatomy and organization. Drug addiction is a widespread relapsing illness that affects both men and women. Sex-dependent differences have been frequently observed in the biological and behavioural effects of substances of abuse, including cannabis. Beside sex differences observed in the cannabinoid-induced effects related to cannabis abuse and dependence, cannabinoids have been shown to exert sex-dependent effects also in other physiological and behavioural aspects, such as food intake and energy balance (more evident in males), or anxiety and depression (more evident in females). Research has just begun to identify factors which could provide a neurobiological basis for gender-based differences in cannabinoid effects, among which, gonadal hormones seem to play a crucial role. Yet, cannabinoid pharmacodynamic and pharmacokinetic may also be important, as sex differences in cannabinoid effects might be due, at least in part, to differences in muscle mass and fat tissue distribution between males and females. Here, we will review both clinical and laboratory-based research evidence revealing important sex-related differences in cannabinoid effects, and put forward some suggestions for future studies to fill the gap in our knowledge of gender-specific bias in cannabinoid pharmacology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590564      PMCID: PMC2931555          DOI: 10.1111/j.1476-5381.2010.00776.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  Expression of cannabinoid receptors and their gene transcripts in human blood cells.

Authors:  E S Onaivi; G Chaudhuri; A S Abaci; M Parker; D H Manier; P R Martin; J R Hubbard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1999-08       Impact factor: 5.067

2.  Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.

Authors:  L Fattore; M S Spano; S Altea; P Fadda; W Fratta
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.

Authors:  S González; T Bisogno; T Wenger; J Manzanares; A Milone; F Berrendero; V Di Marzo; J A Ramos; J J Fernández-Ruiz
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

4.  The clinical pharmacology and dynamics of marihuana cigarette smoking.

Authors:  M Perez-Reyes; S M Owens; S Di Guiseppi
Journal:  J Clin Pharmacol       Date:  1981 Aug-Sep       Impact factor: 3.126

5.  Effects of THC on behavioral measures of impulsivity in humans.

Authors:  Jennifer McDonald; Laura Schleifer; Jerry B Richards; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2003-04-30       Impact factor: 7.853

6.  Cannabis use and mental health in young people: cohort study.

Authors:  George C Patton; Carolyn Coffey; John B Carlin; Louisa Degenhardt; Michael Lynskey; Wayne Hall
Journal:  BMJ       Date:  2002-11-23

7.  Postural syncope after marijuana: a transcranial Doppler study of the hemodynamics.

Authors:  Roy J Mathew; William H Wilson; Robin Davis
Journal:  Pharmacol Biochem Behav       Date:  2003-05       Impact factor: 3.533

8.  CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats.

Authors:  Alan H Tseng; Rebecca M Craft
Journal:  Psychopharmacology (Berl)       Date:  2003-09-30       Impact factor: 4.530

9.  Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.

Authors:  Alan H Tseng; Joseph W Harding; Rebecca M Craft
Journal:  Behav Brain Res       Date:  2004-09-23       Impact factor: 3.332

10.  Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood.

Authors:  Miguel Biscaia; Susana Marín; Beatriz Fernández; Eva M Marco; Marina Rubio; Carmen Guaza; Emilio Ambrosio; Maria Paz Viveros
Journal:  Psychopharmacology (Berl)       Date:  2003-09-04       Impact factor: 4.530

View more
  72 in total

1.  Themed issue: cannabinoids.

Authors:  S P H Alexander; K Mackie; R A Ross
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier.

Authors:  G Moreno-Sanz; O Sasso; A Guijarro; O Oluyemi; R Bertorelli; A Reggiani; D Piomelli
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

3.  BOLD responses to inhibition in cannabis-using adolescents and emerging adults after 2 weeks of monitored cannabis abstinence.

Authors:  Alexander L Wallace; Kristin E Maple; Alicia T Barr; Krista M Lisdahl
Journal:  Psychopharmacology (Berl)       Date:  2020-07-26       Impact factor: 4.530

4.  Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences.

Authors:  Marc D Normandin; Ming-Qiang Zheng; Kuo-Shyan Lin; N Scott Mason; Shu-Fei Lin; Jim Ropchan; David Labaree; Shannan Henry; Wendol A Williams; Richard E Carson; Alexander Neumeister; Yiyun Huang
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-01       Impact factor: 6.200

5.  Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors in rats.

Authors:  Charlotte E Farquhar; Christopher S Breivogel; Thomas F Gamage; Elaine A Gay; Brian F Thomas; Rebecca M Craft; Jenny L Wiley
Journal:  Drug Alcohol Depend       Date:  2018-10-25       Impact factor: 4.492

Review 6.  Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history.

Authors:  Diana Dow-Edwards; Ashley Frank; Dean Wade; Jeremy Weedon; Sari Izenwasser
Journal:  Neurotoxicol Teratol       Date:  2016-09-12       Impact factor: 3.763

7.  Psychobiological responses to unpleasant emotions in cannabis users.

Authors:  Lorenzo Somaini; Matteo Manfredini; Mario Amore; Amir Zaimovic; Maria Augusta Raggi; Claudio Leonardi; Maria Lidia Gerra; Claudia Donnini; Gilberto Gerra
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-20       Impact factor: 5.270

Review 8.  Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder.

Authors:  Alexander Neumeister; Jordan Seidel; Benjamin J Ragen; Robert H Pietrzak
Journal:  Psychoneuroendocrinology       Date:  2014-10-22       Impact factor: 4.905

9.  Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users.

Authors:  Yann Chye; Nadia Solowij; Chao Suo; Albert Batalla; Janna Cousijn; Anna E Goudriaan; Rocio Martin-Santos; Sarah Whittle; Valentina Lorenzetti; Murat Yücel
Journal:  Psychopharmacology (Berl)       Date:  2017-04-01       Impact factor: 4.530

10.  Reduction in Cannabis Use and Functional Status in Physical Health, Mental Health, and Cognition.

Authors:  Larissa J Mooney; Yuhui Zhu; Caroline Yoo; Jonathan Valdez; Kevin Moino; Jung-Yu Liao; Yih-Ing Hser
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.